帕金森病主动整合管理与赋能(PRIME-UK)评估新照护模式的随机对照试验方案
这是一项单中心随机对照试验方案,受试者为帕金森综合征患者及其非正式照护者,随机分为PRIME帕金森病多组分照护模式组或常规照护组。主要结局为采用班戈目标设定访谈测量的目标达成情况,入组时长24个月,总招募目标n=214,主要分析采用意向性治疗原则。
要点
- PRIME-UK试验评估PRIME帕金森病多组分整合照护模式对比常规照护的效果。
- 主要结局为班戈目标设定访谈测量的目标达成情况,入组时长24个月。
- 总招募目标n=214,主要分析采用意向性治疗原则。
核心结论
- 该试验检验新型照护模式能否改善健康与疾病相关指标(包括目标达成)并减少住院,同时较当前常规照护更具成本效益。
- 若该干预能在单中心成功实施,PRIME帕金森病照护模式随后可在多中心整群随机试验中评估。
研究设计与样本
- 单中心随机对照试验,帕金森综合征患者及其非正式照护者随机分为PRIME帕金森病多组分照护模式组或常规照护组。
- 纳入标准为年龄≥18岁、诊断为帕金森综合征、能够提供知情同意,或无同意能力时有亲密朋友或亲属作为个人顾问,且居住在试验地理区域内。
- 每位患者最多可有3名照护者参与,照护者须年龄≥18岁、提供非正式无偿照护且能够提供知情同意。
- 入组时长24个月,总招募目标n=214,主要分析采用意向性治疗原则。
关键数值与推荐
- 主要结局指标为目标达成,采用班戈目标设定访谈测量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: People living with Parkinson's disease experience progressive motor and non-motor symptoms, which negatively impact on health-related quality of life and can lead to an increased risk of hospitalisation. It is increasingly recognised that the current care models are not suitable for the needs of people with parkinsonism whose care needs evolve and change as the disease progresses. This trial aims to evaluate whether a complex and innovative model of integrated care will increase an individual's ability to achieve their personal goals, have a positive impact on health and symptom burden and be more cost-effective when compared with usual care. METHODS: This is a single-centre, randomised controlled trial where people with parkinsonism and their informal caregivers are randomised into one of two groups: either PRIME Parkinson multi-component model of care or usual care. Adults ≥18 years with a diagnosis of parkinsonism, able to provide informed consent or the availability of a close friend or relative to act as a personal consultee if capacity to do so is absent and living in the trial geographical area are eligible. Up to three caregivers per patient can also take part, must be ≥18 years, provide informal, unpaid care and able to give informed consent. The primary outcome measure is goal attainment, as measured using the Bangor Goal Setting Interview. The duration of enrolment is 24 months. The total recruitment target is n=214, and the main analyses will be intention to treat. DISCUSSION: This trial tests whether a novel model of care improves health and disease-related metrics including goal attainment and decreases hospitalisations whilst being more cost-effective than the current usual care. Subject to successful implementation of this intervention within one centre, the PRIME Parkinson model of care could then be evaluated within a cluster-randomised trial at multiple centres.
引用
- Lithander FE, Tenison E, Ypinga J, et al. Proactive and Integrated Management and Empowerment in Parkinson's Disease protocol for a randomised controlled trial (PRIME-UK) to evaluate a new model of care. Trials. 2023. PMID: 36849987. doi:10.1186/s13063-023-07084-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。